New chief of FDA garners mixed reviews.(BUSINESS)

From: The Washington Times (Washington, DC) | Date: September 27, 2005 | Copyright information

Byline: Marguerite Higgins, THE WASHINGTON TIMES

The Food and Drug Administration's new acting commissioner is getting compliments for his government experience but criticism for his history of seeking quick drug approvals.

President Bush on Friday named Dr. Andrew C. von Eschenbach to replace former FDA Commissioner Dr. Lester M. Crawford, 67, who resigned suddenly as head of the agency that regulates food and prescription-drug marketing.

Dr. Crawford cited his age as the reason for leaving the federal agency. The FDA has been criticized in the past few years as ...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Mixed reviews for new FDA chief.
; ...to emergency contraception. Dr. von Eschenbach, a 63-year-old cancer survivor...death from cancer by 2015. Dr. von Eschenbach is expected to run both agencies...praised the speedy appointment of Dr. von Eschenbach to the FDA helm. His leadership...
Supplements' fate under new FDA chief uncertain
; Dr. Andrew von Eschenbach, who was appointed acting...only guessing whether von Eschenbach's appointment will help...I have no vibe yet on Dr. von Eschenbach. He's...Natural Product Alliance. "Dr. von Eschenbach is a physician who comes...
Von Eschenbach confirmed for FDA.(Food and Drug Administration)(Dr. Andrew von Eschenbach)(Brief article)
; ...Chuck Grassley (R-Iowa), one of Dr. von Eschenbach's most vocal critics. As Finance...Sen. Grassley maintains that Dr. von Eschenbach has stonewalled committee investigators...warned his colleagues that Dr. von Eschenbach was a prime illustration of...
Safety & Science
; ...this important federal agency, Dr. von Eschenbach has faced an avalanche of difficult...from prescription drug use. Dr. von Eschenbach says that one cannot look at...utilized in diverse populations," Dr. von Eschenbach says. "We'll do it by using...
Tough tasks for new FDA chief.(COMMENTARY)
; ...Eschenbach to fill the slot. Dr. von Eschenbach knows how to think big. As...needed to beat the disease. Now Dr. von Eschenbach faces a bigger battle: taking...must be at or near the top of Dr. von Eschenbach's agenda. Long-term regulatory...
Von Eschenbach confirmed for FDA.(POLICY & PRACTICE)(Brief article)
; ...Chuck Grassley (R-Iowa), one of Dr. von Eschenbach's most vocal critics. As Finance...Sen. Grassley maintains that Dr. von Eschenbach has stonewalled committee investigators...warned his colleagues that Dr. von Eschenbach was a prime illustration of...
Von Eschenbach confirmed for FDA.(Policy & Practice)(appointments at Food and Drug Administration)(Brief article)
; ...Iowa), who has been one of Dr. von Eschenbach's most vocal critics. As chairman...Sen. Grassley maintains that Dr. von Eschenbach has stonewalled committee investigators...warned his colleagues that Dr. von Eschenbach was a prime illustration of...
Von Eschenbach confirmed for FDA.(POLICY & PRACTICE)(Food and Drug Administration)(Brief article)
; ...Sen. Grassley has been one of Dr. von Eschenbach's most vocal critics. As chairman...Sen. Grassley maintains that Dr. von Eschenbach has stonewalled committee investigators...colleagues across the aisle that Dr. von Eschenbach was a prime illustration of...
National Cancer Institute without full-time leadership.
; ...people every year. Dr. Andrew von Eschenbach, a 64-year-old urologist...House said that Dr. John Niederhuber, von Eschenbach's deputy, has day-to...interviewed, and von Eschenbach didn't return a call seeking comment. Dr. H. Shelton Earp...
Family Research Council Announces Opposition to Bush's FDA Nominee
; ...in a letter to Sen. Enzi: "Dr. von Eschenbach has shown a history of ignoring...FDA both during and prior to Dr. von Eschenbach taking over as acting FDA Commissioner...indication the FDA is serious under Dr. von Eschenbach about investigating the ...